EIF2AK4 and pulmonary venoocclusive disease: We know that PVOD is due to biallelic mutations in EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4) or induced by exposure to specific chemotherapeutic agents or organic solvents (16).